The 15% Indirect Cost Cap Nearly Gutted American Research. Here Is How Universities Fought It Off.

For about nine months in 2025, the federal government attempted something that had never been tried at scale: capping the indirect cost reimbursement rate on research grants at 15 percent across NIH, NSF, DOE, and DOD simultaneously. Had it stuck, the policy would have drained an estimated $4 billion per year from the nation's research universities — money that pays for the laboratories, libraries, compliance offices, and infrastructure that make federally funded science possible.

It did not stick. But the battle to defeat it — fought across multiple federal courtrooms, in congressional appropriations committees, and through an unprecedented coalition of university presidents, state attorneys general, and biomedical advocacy groups — revealed just how fragile the financial architecture of American research really is.

What Indirect Costs Actually Pay For

The term "indirect costs" has always been the policy's worst enemy in the public debate. To anyone outside the research enterprise, it sounds like waste — a tax on taxpayer money that disappears into university bureaucracies. The reality is more prosaic and more essential.

When a researcher receives an NIH R01 grant for $250,000 in direct costs — reagents, equipment, graduate student stipends, travel — the university also receives reimbursement for the costs of hosting that research. That includes building maintenance for the lab space, utilities, hazardous waste disposal, Institutional Review Board operations for human subjects research, IACUC oversight for animal protocols, research computing infrastructure, library access to scientific journals, sponsored programs administration, and the compliance machinery required to satisfy the roughly 300 federal regulations that apply to any institution receiving federal research funds.

These costs are real. They are auditable. And they are negotiated institution by institution with the federal government through a process that produces a Negotiated Indirect Cost Rate Agreement, or NICRA. The median negotiated rate across American research universities in 2024 was approximately 56 percent of direct costs, meaning that for every dollar of direct research spending, the university received 56 cents to cover the infrastructure that made the research possible. Rates ranged from roughly 30 percent at smaller institutions to over 70 percent at the most research-intensive universities.

The effective rate — what universities actually recovered after various caps and exclusions — was lower, averaging around 42 percent. The gap between negotiated and effective rates means universities were already absorbing billions in unreimbursed research costs annually before the 15 percent cap was proposed.

The Coordinated Attack

The cap did not come from a single agency. Between February and May 2025, four agencies moved in rapid succession:

NIH issued Notice NOT-OD-25-068 on February 7, 2025, imposing a 15 percent cap on indirect cost recovery for all new grants and modifying terms for existing awards to institutions of higher education.

DOE followed on April 11 with Policy Flash PF-2025-22, capping higher education rates at 15 percent. Subsequent policy flashes in May extended the cap to nonprofits and for-profits at 15 percent and state and local governments at 10 percent.

NSF announced it would "apply a standard indirect cost rate not to exceed 15 percent to all grants and cooperative agreements awarded to IHEs."

DOD issued a memorandum on May 14 stating the department would cap rates at 15 percent for all financial awards to higher education institutions, effective June 4 for new awards and June 13 for existing ones.

The coordination was unmistakable. Four agencies, each with its own statutory authority, grant-making traditions, and institutional relationships, moved within weeks of each other to implement functionally identical policies. The administration's framing was consistent: the caps would "save taxpayers money" by reducing overhead payments. DOE projected $405 million in annual savings from its $2.5 billion external research grants budget.

What the savings calculation omitted was who would absorb those costs. Universities cannot simply stop maintaining lab buildings, stop operating compliance offices, or stop disposing of hazardous waste because the federal government decided to reimburse less. The costs do not disappear — they shift to institutional budgets, which means higher tuition, reduced research capacity, or both.

The Legal Counterattack

The response from the research community was faster and more unified than the administration anticipated.

A coalition of 22 state attorneys general filed suit. Major research universities joined independently and through associations. Biomedical advocacy groups — patient organizations that depend on NIH-funded research for treatments and cures — added their weight.

The legal arguments centered on three points. First, federal law requires that indirect cost rates be established through negotiation between institutions and their cognizant federal agency, not imposed unilaterally. The negotiation process — codified in 2 CFR 200.414 of the Uniform Guidance — exists precisely to account for the legitimate cost differences between institutions. A blanket cap eliminated the entire statutory framework.

Second, the agencies had bypassed the Administrative Procedure Act's notice-and-comment requirements. Changing a fundamental cost reimbursement policy through internal policy flashes and guidance notices, rather than through formal rulemaking, denied affected institutions the procedural protections Congress mandated for regulatory changes of this magnitude.

Third, and most practically, applying the caps to existing awards — grants already in progress with budgets built on negotiated rates — constituted an impermissible retroactive change to contractual terms. Institutions had accepted awards and committed resources based on budgets that included their negotiated indirect cost rates. Changing those rates mid-award was not a policy adjustment — it was a breach.

The courts agreed on all three counts. On April 4, 2025, a federal judge issued a permanent injunction against the DOE cap. On June 30, the Massachusetts court vacated the higher education cap entirely. The 1st U.S. Circuit Court of Appeals unanimously upheld the ruling blocking the NIH cap in January 2026, concluding that NIH had "violated statutory law and the agency's own regulatory procedures."

Congress Closes the Door

While the courts were blocking implementation, Congress was making the prohibition permanent — or at least as permanent as an appropriations rider can be.

The Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 included explicit language directing DOE, NSF, NASA, and the Department of Commerce to "apply indirect cost rates to the same extent and in the same manner as in FY 2024." The statute prohibited these agencies from using appropriated funds to modify negotiated rates.

The National Defense Authorization Act for Fiscal Year 2026 took a different approach for DOD: it prohibited the Secretary of Defense from changing indirect cost rates for grants and contracts to higher education institutions and nonprofits until the Secretary certified that DOD had worked with the research community to develop an alternative indirect cost model. Given the complexity of that certification requirement, the practical effect is a multi-year freeze on DOD rate changes.

On January 27, 2026, DOE formally rescinded all prior indirect cost cap policy flashes through PF-2026-30. The practical result: all agencies are back to negotiated rates as they existed in FY2024.

The Damage That Was Done

The caps were in effect, or threatening to take effect, for roughly nine months. During that period, the uncertainty alone caused measurable damage.

A New York Times analysis found that the policy could have cost some of the top research universities over $100 million per year. But the impact would not have been distributed evenly. Smaller institutions — regional universities, historically Black colleges and universities, emerging research institutions — faced a disproportionate threat. These schools often have higher negotiated rates because they lack the economies of scale that large research universities enjoy, and they have less institutional endowment to absorb unreimbursed costs.

The period of uncertainty also chilled grant applications. Principal investigators at institutions whose rates were in flux reported delaying submissions, uncertain whether to budget at their negotiated rate or the proposed 15 percent cap. Program officers at NIH and NSF reported confusion about which rate to apply during the transition period. The downstream effect on the research pipeline — proposals not submitted, collaborations not formed, early-career researchers discouraged — is harder to quantify but was widely reported across the academic research community.

What Researchers and Institutions Should Know Now

The immediate crisis is over, but the landscape has shifted in ways that matter for anyone writing grant proposals in 2026.

Your negotiated rate is intact — for now. If your institution has a current NICRA, it applies to all new and existing awards. The congressional language in the FY2026 appropriations acts is clear. But appropriations riders expire with each fiscal year. The protection extends through September 30, 2026. What happens in FY2027 depends on the next appropriations cycle.

Executive Order 14332 introduced a softer pressure. While the direct cap was defeated, EO 14332 directed OMB to revise the Uniform Guidance to give agencies a basis for "prioritizing" applicants who propose lower indirect cost rates. This is not a cap — it is a competitive consideration. In practice, it means reviewers at some agencies may now treat lower overhead as a positive differentiator. Institutions should be prepared to explain the value their indirect cost infrastructure provides, not just assert that their rate is federally negotiated.

The de minimis rate increased to 15 percent. Ironically, the same number that was proposed as a cap became the new floor. The revised 2 CFR 200 raised the de minimis indirect cost rate from 10 percent to 15 percent for organizations that do not have a negotiated rate. For small nonprofits and community organizations entering the federal grant space for the first time, this is a meaningful improvement.

Build institutional advocacy capacity. The 15 percent cap was defeated because universities, state AGs, and research advocates organized quickly and effectively. The next challenge — whether it comes through appropriations, executive action, or regulatory revision — will require the same speed. Institutions that maintain relationships with their congressional delegations, participate in research advocacy organizations, and track OMB and agency policy changes are better positioned to respond.

The indirect cost rate battle of 2025 was the closest the federal government has come to fundamentally restructuring how research is funded in the United States. The system held — but only because courts, Congress, and the research community pushed back with unusual speed and coordination. For researchers navigating this landscape, Granted tracks funding opportunities across every major federal agency, so you can focus on the science while the policy settles.